Effect of simvastatin in gentamicin induced nephrotoxicity in albino rats

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue 1, 2012, Pages 36-40

  Chinnapa Reddy, V ^a   Amulya, V ^a   Anusha Lakshmi, Ch ^a   Bala Praveen Kumar Reddy, D ^a   Pratima, D ^a   Thanga Thirupathi, A ^a   Pavan Kumar, K ^b   Sengottuvelu, S ^b  

^a Sankaralingam Bhuvaneshwari College of Pharmacy   (India)

^b NANDHA COLLEGE OF PHARMACY   (India)

Author keywords

Albino rats; Gentamicin; Nephrotoxicity; Simvastatin

Indexed keywords

GENTAMICIN; GLUTATHIONE; SIMVASTATIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; TREATMENT DURATION; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

EID: 84856770083     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Elfarra AA, Duescher RJ, Sausen PJ, Ohara TM, Cooley AJ. Methimazole protection of rats against gentamicin-induced nephrotoxicity. Can J Physiol Pharmacol 1994; 72: 1238-44.
2. Abdel Raheem IT, Abdel Ghany AA, Mohamed GA. Protective effect of quercetin against gentamicin-induced nephrotoxicity in rats. Biol Pharm Bull 2009; 32: 61-7.
3. Sandhu JS, Sehgal A, Gupta O, Singh A. Aminoglycoside nephrotoxicity revisited. J Ind Acad Clin Med 2007; 8: 331-3.
4. Watanabe A, Nagai J, Adachi Y, Katsube T, Kitahara Y, Murakami T, et al. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside building receptor antagonist. J Control Release 2004; 95: 423-33.
5. Antoine DJ, Srivasthava A, Pirmohamed M, Park BK. Statin inhibits aminoglycoside accumalation and cytotoxicity to renal proximal tubule cells. Biochem pharmacol 2010; 79: 647-54.
6. Bayorh MA, Gafana AA, Eatman D, Walton M, Feuerstein GZ. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens 2005; 18: 1496-502.
7. Vieira JM, Rodrigues LT, Mantovani E, Delle H, Matter AL, et al. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron physiol 2005; 101: 82-91.
8. Knight SF, Yuvan J, Roy S, Imig JD. Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension. Am J Physol 2010; 298: 86-94.
9. Wei P, Grimm PR, Settles DC, Balwanz CR, padanilam BJ, Sansom SC. Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail 2009; 31: 503-13.
10. Lin CL, Tung CW, Huang WJ, Chang PJ, Yang JT, Wang JY. Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. Am J Nephrol 2008; 28: 290-7.
11. Upaganlawar A, Mamta F, Shivkumar R, Balaraman R. Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats. Indian J Exp Biol 2006; 44: 416-418.
12. Bonsnes RW, Taussky HH. On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 1945; 158: 581-91.
13. Fawcett JK, Scott E. A rapid and precise method for the determination of urea. J Clin Pathol 1960; 13: 156-9.
14. Watnabe A, Nagai J, Adachi Y, Katsube T, Kithahara Y, Murakami T, et al. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside biniding receptor antagonists. J Control Release 2004; 95: 422-33.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissu by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
16. Ellman GL. Tissue sulfhydryl groups. Archives Biochem Biophy 1959; 82: 70-77.
17. Sheehan DC, Hrapchak BB. Theory and practice of histotechnology, 2nd ed. London: Monsby Co., St. Louis, Toronto; 1980. p. 481.
18. Bancroft JD, Cook HC. Manual of histological techniques and their diagnostic application. 2nd ed. Edinburgh: Churchill Livingstone; 1984. p. 457.
19. Finco DR, Duncan JR. Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature. J Am Vet Med Assoc 1976; 168: 593-601.
20. Perrrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-53.
21. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007; 106: 26-31.
22. Pedrazha chaverri J, Maldonado PD, Barrera D, Ceron A, Medina Campos ON, Hernandez Pando R, et al. Garlic ameliorates nephrotoxicity: relation to antioxidant enzymes. Free Radiac Biomed 2000; 29: 602-11.
23. Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, et al. protective role of caffeic acid phenethyl ester (cape) on gentamicin inducled actute renal toxicity in rats. Toxicol 2005; 24: 33-37.
24. Maldonado PD, Barrera D, Rivero I, Mata R, Hernandez PR, et al. Anto oxidant S-allylcysteine prevents gentamicin induced oxidative stress and renal damage. Free Rad Biol Med 2003; 35: 317-24.
25. Walker PD, Barri Y, Shah SV. Oxidant mechanisms in gentaamicin nephrotoxicity. Renal Fail 1999; 21: 433-42.
26. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J. Antioxidant defense system in diabetic kidney: a time course study. Life Sci 1997; 60: 667-79.